NTHI Stock Analysis: Buy, Sell, or Hold?

NTHI - NeOnc Technologies Holdings, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$5.45
-1.04 (-16.02%) ▼
5d: +34.24%
30d: +6.45%
90d: -44.22%
BUY
HIGH Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 08, 2026 0d

Get Alerted When NTHI Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: NTHI shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NTHI is currently trading at $5.45, which is considered fair relative to its 30-day fair value range of $4.53 to $6.00.

Technical Outlook: Technically, NTHI is in a strong downtrend. Immediate support is located at $3.87, while resistance sits at $6.84. Short-term momentum is weak, with the stock down 16.0% recently.

Market Sentiment: NTHI has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.00 (+175.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $4.53 - $6.00
Company Quality Score 55/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 81.6%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-16.0%)
  • BULLISH: Trading 175.2% below Wall St target ($15.00)

Trading Range Analysis

30-Day Trading Range $4.53 - $6.00
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $3.87
Resistance Level $6.84
Current Trend Strong Downtrend
Technical data as of May 8, 2026

Fundamental Context

Forward P/E (Next Year Est.) -10.28
Wall Street Target $15.00 (+175.2%)
Revenue Growth (YoY) -100.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 08, 2026 9:48 PM ET
Data refreshes hourly during market hours. Next update: 10:47 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
11
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Yousha Neman-Ebrahim BUY 500 shares 2026-04-23
Amir F Heshmatpour BUY 10000 shares 2026-04-23
Amir F Heshmatpour BUY 10000 shares 2026-04-10

Unlock Insider Activity

See real-time buying/selling by company executives for NTHI.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
LEGN
Legend Biotech Corp
STRONG BUY
22 analysts
$57 54 HOLD
RARE
Ultragenyx
STRONG BUY
20 analysts
$53 60 HOLD
JAZZ
Jazz Pharmaceuticals PLC
STRONG BUY
18 analysts
$226 66 BUY
KYMR
Kymera Therapeutics Inc
STRONG BUY
20 analysts
$119 57 HOLD
VKTX
Viking Therapeutics Inc
STRONG BUY
19 analysts
$92 50 HOLD

More Analysis for NTHI

NTHI Technical Chart NTHI Price Prediction NTHI Earnings Date NTHI Investment Advisor NTHI Fair Price Analyzer NTHI Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals